Patents by Inventor Amel Dudakovic

Amel Dudakovic has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220125853
    Abstract: This document provides materials and methods for enhancing bone cell differentiation. For example, compositions containing an epigenetic drug, an actin modulator, and/or one or more osteogenic differentiation factors that can be used to enhance bone cell differentiation are provided.
    Type: Application
    Filed: January 10, 2022
    Publication date: April 28, 2022
    Inventors: Andre J. van Wijnen, Amel Dudakovic
  • Publication number: 20200316130
    Abstract: This document provides materials and methods for enhancing bone cell differentiation. For example, compositions containing an epigenetic drug, an actin modulator, and/or one or more osteogenic differentiation factors that can be used to enhance bone cell differentiation are provided.
    Type: Application
    Filed: August 17, 2017
    Publication date: October 8, 2020
    Inventors: Andre J. van Wijnen, Amel Dudakovic
  • Publication number: 20180133211
    Abstract: This document provides methods and materials involved in promoting new bone formation for the treatment of medical conditions such as osteoporosis, bone defects, bone injury (e.g., fractures) implant ingrowth, and joint/spine fusions. For example, methods and materials for using sulforaphane and/or EZH2 polypeptide inhibitors (e.g., GSK126 or UNC1999) to treat osteoporosis, bone fractures and defects, implant ingrowth, and joint fusions are provided.
    Type: Application
    Filed: May 19, 2016
    Publication date: May 17, 2018
    Applicant: Mayo Foundation for Medical Education and Research
    Inventors: Andre J. van Wijnen, Scott M. Riester, Emily T. Camilleri, Amel Dudakovic, Roman Thaler, John W. Sperling